Pulmonology Department, Hospital de Pediatria Dr. Juan P. Garrahan, Combate de los Pozos 1881 (1245), Buenos Aires, Argentina.
Fundación Pablo Cassará, Buenos Aires, Argentina.
BMC Pulm Med. 2024 Jun 6;24(1):270. doi: 10.1186/s12890-024-03058-x.
The evaluation of the asthmatic patient is usually based on clinical and functional parameters that do not necessarily evidence the degree of airway inflammation. The aim of this study was to analyze whether clinical scores (CS) correlate with spirometry (S), impulse oscillometry (IO) and FeNO, in severe asthmatic children.
A multicentric, prospective, cross-sectional study was conducted over a 12-month period. All SA patients (6-18 years old) followed-up in the Pulmonology Department were recruited. CS, FeNO measurements, IO and S were consecutively performed on the same day. Asthma control was ascertained using ACT and GINAq. A cut-off value of ≥ 25 parts per billion (ppb) was used to define airway inflammation.
Eighty-one patients were included. ACT: 75% (n 61) were controlled; GINAq: 44.5% (n 36) were controlled; 39.5% (n 32) were partly controlled, and 16% (n 13) were uncontrolled. FeNO had a median value of 24 ppb (IQR 14-41); FeNO ≥ 25 ppb was observed in 49% of patients (n 39). ROC AUC for FeNO vs. ACT was 0.71 (95%CI 0.57-0.86), PPV 0.47, NPV 0.87, SE 0.61, SP 0.80; FeNO vs. GINAq was ROC AUC 0.69 (95%CI 0.54-0.85), PPV 0.34, NPV 0.91, SE 0.62, SP 0.77; Youden cut-off FeNO > 39 ppb for both CS.
In severe asthmatic children, current symptoms control as evidenced by ACT and GINA correlates with low FeNO values. Clinical scores showed good correlation with airway inflammation.
哮喘患者的评估通常基于临床和功能参数,而这些参数并不一定能证明气道炎症的程度。本研究旨在分析严重哮喘儿童的临床评分(CS)是否与肺功能(S)、脉冲振荡(IO)和 FeNO 相关。
进行了一项为期 12 个月的多中心、前瞻性、横断面研究。招募了所有在呼吸科接受随访的严重哮喘患儿(6-18 岁)。CS、FeNO 测量、IO 和 S 在同一天连续进行。使用 ACT 和 GINAq 来确定哮喘控制情况。使用≥25 皮克/十亿(ppb)的截止值来定义气道炎症。
共纳入 81 例患者。ACT:75%(n=61)得到控制;GINAq:44.5%(n=36)得到控制;39.5%(n=32)部分控制,16%(n=13)未得到控制。FeNO 的中位数为 24 ppb(IQR 14-41);49%的患者(n=39)FeNO≥25 ppb。FeNO 与 ACT 的 ROC AUC 为 0.71(95%CI 0.57-0.86),PPV 为 0.47,NPV 为 0.87,SE 为 0.61,SP 为 0.80;FeNO 与 GINAq 的 ROC AUC 为 0.69(95%CI 0.54-0.85),PPV 为 0.34,NPV 为 0.91,SE 为 0.62,SP 为 0.77;CS 中最佳的 FeNO 截断值为>39 ppb。
在严重哮喘儿童中,ACT 和 GINA 所证明的当前症状控制与低 FeNO 值相关。临床评分与气道炎症有很好的相关性。